Exchanges
BSE, NSE
Industry
Pesticides & Agrochemicals
Issue
Book building

GSP Crop Science IPO

₹356.25

+11.33% on listing

Listing-day close · NSE · 24 Mar 2026 · issue price ₹320

GSP Crop Science’s ₹400 crore IPO was priced at ₹320 a share. It listed on the NSE on 24 Mar 2026 and closed its first day at ₹356.25, up 11.33% on the issue price.

Timeline

  1. Opens
  2. Closes
  3. Allotment
  4. Refunds
  5. Shares in demat
  6. Listing

Issue details

Issue size
₹400 Cr
Fresh issue
₹240 Cr
Offer for sale
₹160 Cr
Lot size
46 shares
Minimum investment
₹14,720
Face value
₹10
Registrar
MUFG Intime India

Subscription

GSP Crop Science IPO subscription by investor category
CategoryShares offeredTimes subscribed
Total—1.44×

Overall, from the basis of allotment.

Financials and valuation

Market cap (post-issue)
₹1,489 Cr
P/E (post-issue)
9.2
EPS (post-issue)
₹21.22
ROE
15.62%
ROCE
15.45%
Debt to equity
0.55
EBITDA margin
16.45%
PAT margin
9.56%
Promoter holding
98.32% → 71.72%

Financials as of 30 Sep 2025, from the offer documents.

Listing

Listing date
24 Mar 2026
Issue price
₹320
Open
₹328.00
High
₹364.00
Low
₹328.00
Close
₹356.25

Listing day on the NSE. The close was +11.33% on the issue price.

FAQs

When did the GSP Crop Science IPO open and close?

It opened on 16 Mar 2026 and closed on 18 Mar 2026.

What was the GSP Crop Science IPO price?

The price band was ₹304–320 a share. The final issue price was ₹320.

What is the lot size and minimum investment?

One lot is 46 shares, ₹14,720 at ₹320 a share. Retail investors apply in whole lots.

How much did GSP Crop Science raise?

₹400 crore: ₹240 crore of new shares and ₹160 crore offered by existing shareholders.

How many times was the GSP Crop Science IPO subscribed?

1.44 times overall.

How did GSP Crop Science list?

It listed on the NSE on 24 Mar 2026 at ₹328.00 and closed the day at ₹356.25, up 11.33% on the ₹320 issue price.

Who is the registrar of the GSP Crop Science IPO?

MUFG Intime India handles the allotment, refunds and credit of shares.

For information only. Not investment advice or a research report.

Full disclaimer

See how an IPO fits your plan

Armor checks every holding against your goals, risk and timeline.

Get the app